MedPath

Subcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung Cancer

Completed
Conditions
Non Small Cell Lung Cancer
Registration Number
NCT07099105
Lead Sponsor
Korea University Guro Hospital
Brief Summary

The goal of this observational study is compared the perioperative outcomes of robotic lobectomy using the SP system via the subcostal approach with those of multi-port robotic lobectomy using the Xi system via the intercostal approach.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
339
Inclusion Criteria
  • patients aged > 18 years who underwent RATS lobectomy for NSCLC at the Korea University Guro Hospital between January 2017 and December 2024
Exclusion Criteria
  • patients who underwent Viedo-assisted thoracic surgery lobectomy
  • patients who underwent robotic lobectomy with other combined surgery
  • patients who received neoadjuvant therapy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative painPostoperatively day 0,1,2,3

Postoperative pain using visual analog scale (minimum =0, maximum=10), A lower value reflects a lesser degree of pain perception (lower scores mean a better outcome)

Secondary Outcome Measures
NameTimeMethod
chest tube durationPerioperative

Chest tube duration refers to the number of days a thoracic drain remains in situ following pulmonary surgery. The duration is measured in days (minimum: 1, maximum: no defined). Lower scores indicate a better outcome.

Trial Locations

Locations (1)

Korea University Guro Hospital

🇰🇷

Seoul, Korea, Republic of

Korea University Guro Hospital
🇰🇷Seoul, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.